Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04189861 · ClinicalTrials.gov registry record
Use of Brain Wave Monitoring During Surgery to Reduce Postoperative Cognitive Dysfunction
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 31
- Enrollment target
NCT04189861: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT04189861 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04189861 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This research study is being done to determine if indices derived from monitoring brain wave activity while under general anesthesia will predict the likelihood of post-operative cognitive dysfunction in patients over 60 years old.
Primary Outcome
The investigators will use a Composite Cognitive Change Score (between baseline and 3 months) to determine POCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2025-11-11 |
What the finished NCT04189861 record still lists
NCT04189861 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04189861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04189861 about?
NCT04189861 is a clinical study titled "Use of Brain Wave Monitoring During Surgery to Reduce Postoperative Cognitive Dysfunction". This research study is being done to determine if indices derived from monitoring brain wave activity while under general anesthesia will predict the likelihood of post-operative cognitive dysfunction in patients over 60 years old.
What is the current status of trial NCT04189861?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2020-01-24. Estimated completion is 2025-11-11.
Who is sponsoring clinical trial NCT04189861?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI